Kura Oncology Inc (KURA) Stock Analysis

Kura Oncology Inc (KURA) is a publicly traded company in the HEALTHCARE sector. It trades at $8.97, carries a market capitalization of $802.08M. This page summarizes the public market data, fundamentals, and frequently asked questions for KURA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Kura Oncology Inc currently has a Bullish sentiment score of 0.41.

About Kura Oncology Inc

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, focused on the discovery and development of innovative therapies for genetically defined tumors in oncology. With a robust pipeline of targeted treatment candidates, Kura aims to address significant unmet medical needs in cancer care. The company's dedication to rigorous clinical development, bolstered by strategic partnerships, positions it to deliver transformative therapeutic options and enhance p...

GNG Research Analysis

GNG Research scores Kura Oncology Inc (KURA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KURA.

Frequently Asked Questions

Does KURA pay dividends?

Kura Oncology Inc (KURA) does not currently pay a regular dividend.

What is KURA's market cap?

Kura Oncology Inc (KURA) has a market capitalization of $802.08M with a current stock price of $8.97.